Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation

NCT03058627 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 454

Last updated 2023-12-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of routine FFR-guided complete revascularization with PCI compared to conservative management in patients with concomitant coronary artery disease who are undergoing TAVI.

Conditions

Interventions

PROCEDURE

PCI

FFR guided PCI

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Lund University Hospital

    collaborator OTHER
  • Karolinska University Hospital

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Tampere University Hospital

    collaborator OTHER
  • Oulu University Hospital

    collaborator OTHER
  • Turku University Hospital

    collaborator OTHER_GOV
  • Sahlgrenska University Hospital

    collaborator OTHER
  • Pauls Stradins Clinical University Hospital

    collaborator OTHER
  • Thomas Engstrom

    lead OTHER

Principal Investigators

  • Thomas Engstrøm, MD, DMSC, PhD · Rigshospitalet University Hospital, Denmark

  • Jacob Lønborg, MD, DMSC, PhD · Rigshospitalet University Hospital, Denmark

  • Lars Søndergaard, MD, DMSc, PhD · Rigshospitalet University Hospital, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2024-01-15
Completion
2027-11-15

Countries

  • Denmark
  • Finland
  • Latvia
  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03058627 on ClinicalTrials.gov